Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
combo drug
Biotech
Novavax's 2nd round of job cuts impacted 12% of staff
Novavax CEO John Jacobs said he used 2023 to right the ship financially and strategically align with the reality of the COVID vaccine market.
Max Bayer
Jan 31, 2024 11:57am
Kura's leukemia drug works best when tacked onto existing combo
Jan 30, 2024 11:15am
UPDATE: TG disbands cancer program after pulling U2 request
Apr 18, 2022 11:11am
Allergan injects Tobira candidate into Novartis NASH combo trial
Apr 18, 2017 3:46am
